Sensitivity Analysis in Cost-Effectiveness Studies: From Guidelines to Practice

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.4, 2011-04, pp. : 297-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Importance of Cost Inputs and Sensitivity Analyses in a Cost-Effectiveness Analysis

By PharmD Jenna L. Yoder

Clinical Drug Investigation, Vol. 28, Iss. 7, 2008-01 ,pp. : 461-462

Adis International

Access to resources Recommend Favorite

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine Shabaruddin Fatiha H

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

From Randomised Clinical Trials to Clinical Practice: A Pragmatic Cost-Effectiveness Analysis of Paclitaxel in First-Line Therapy for Advanced Ovarian Cancer

By Samuel Limat

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 633-641

Adis International

Access to resources Recommend Favorite

Estimating `Costs' for Cost-Effectiveness Analysis

By Miners Alec

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 745-751

Adis International

Access to resources Recommend Favorite

Subgroups and Heterogeneity in Cost-Effectiveness Analysis

By Sculpher Mark

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 799-806

Adis International

Access to resources Recommend Favorite